‍

In this episode, we take a deep dive into the findings from a recent Forbeck Forum on Cell Death in Cancer Therapy, chaired by Kristopher Sarosiek, PhD (Harvard) and Cristina Muñoz-Pinedo, PhD (IDIBELL).The discussion explores—in accessible, lay-friendly terms—how cancer treatments ultimately work by killing cancer cells, and why understanding the differences between cancer cell death and normal cell death is crucial for improving therapies. Drs. Sarosiek and Muñoz-Pinedo explained how various treatments trigger cell death, how the immune system can be activated or suppressed depending on the type of cell death, and why minimizing collateral damage to healthy tissues remains a central challenge.